April 25, 2026 | Health News | SUNTV Global Channel Reporting
In a historic breakthrough in the fight against malaria, the (WHO) has approved the first-ever malaria treatment specifically designed for newborns and infants.
The newly approved drug, artemether-lumefantrine, marks a significant step forward in protecting the most vulnerable victims of the mosquito-borne disease. Until now, infants have been treated using medications formulated for older children — a practice that increased the risk of incorrect dosing, harmful side effects, and potential toxicity.
According to the WHO, the treatment has received “prequalification” status, meaning it meets global standards for quality, safety, and effectiveness. This approval is expected to boost access to safe and reliable malaria treatment for millions of babies, particularly in Africa, where the burden of the disease remains highest.
Speaking on the development, WHO Director-General described the moment as a turning point in global health.
“For centuries, malaria has taken children from families and drained communities of hope. But today, that narrative is changing,” he said, highlighting advances such as vaccines, improved diagnostics, and next-generation mosquito nets.
Despite progress, malaria continues to pose a major global threat. In 2024 alone, there were an estimated 282 million cases and 610,000 deaths across 80 countries. Africa accounted for a staggering 95% of both infections and fatalities, with children under five making up nearly three-quarters of the deaths.
Health experts warn that challenges such as drug resistance, insecticide resistance, weak diagnostic systems, and declining international funding are slowing progress in malaria control efforts.
The WHO emphasized that this new approval will help bridge a critical treatment gap affecting approximately 30 million babies born each year in malaria-endemic regions.
With this milestone, global health leaders say the goal of ending malaria is now within reach — but only if governments and partners maintain strong political will and financial commitment.
SUNTV Global Channel will continue to monitor developments in global health and bring you timely updates.
